4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-016183
CHIEF MEDICAL OFFICER sold 28,600 shares at an average $17.65 ($504,758)
- CHIEF MEDICAL OFFICER acquired 28,600 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-12-07 | Option exercise 10b5-1 | +28,600 | $1.86 | $53,196 | 73,492 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-12-07 | Sale 10b5-1 | −7,380 | $17.54 | $129,445 | 66,112 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-12-07 | Sale 10b5-1 | −13,017 | $17.64 | $229,620 | 53,095 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-12-07 | Sale 10b5-1 | −6,702 | $17.75 | $118,961 | 46,393 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-12-07 | Sale 10b5-1 | −1,501 | $17.81 | $26,733 | 44,892 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2023-12-07 | Option exercise · Share Option 10b5-1 | −28,600 | 111,217 | D | ||
| Open-market sales · 28,600 sh · avg $17.65 · $504,758 | |||||||
Loading xslF345X05/form4-12112023_041201.xml…